7 Feb
2026
Understand the FDA's three-tier system for manufacturing changes in pharmaceuticals: PAS, CBE-30, and annual reports. Learn how to classify changes, avoid violations, and stay compliant with global regulations.
Triptans are common migraine treatments but have serious interactions and limitations. Learn about safe usage, side effects, and when to try alternatives. Find out why some people don't respond and what to do next.
Learn how to safely dispose of chemotherapy drugs at home to protect your family and environment. This guide covers essential protocols, common mistakes, and expert-approved methods for handling hazardous cancer medications.
Life transitions like moving, changing jobs, or going through a breakup often cause medication adherence to drop. Learn science-backed strategies to stay on track during stress, from anchor routines to social support and therapy. No fluff. Just what works.
Palliative care in cancer focuses on controlling pain and improving quality of life through evidence-based methods like the WHO analgesic ladder, targeted medications, and early intervention. Over 80% of cancer pain can be managed effectively with the right approach.
Learn how the ABCDE rule helps spot melanoma early, why it's not foolproof, and what really matters when deciding if a mole needs a biopsy. Early detection saves lives.
Many seniors fall because of medications that cause dizziness, low blood pressure, or confusion. Learn which drugs are most dangerous and how to reduce fall risk with simple medication reviews.
The U.S. drug supply chain uses advanced serialization and traceability under the DSCSA to prevent counterfeit medications from reaching patients. Learn how barcode tracking, authorized partners, and electronic data exchange protect your prescriptions.
Ataxia causes severe coordination loss due to cerebellar damage. Effective neurological rehabilitation uses task-specific training, biofeedback, and specialized therapy to improve balance, speech, and daily function - not just generic exercises.
Starting January 2026, Medicare will pay significantly less for 10 high-cost prescription drugs thanks to new price negotiations under the Inflation Reduction Act. Learn how it works, which drugs are affected, and what it means for your out-of-pocket costs.